These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33296271)

  • 1. Targeted Screening for HIV Pre-Exposure Prophylaxis Eligibility in Two Emergency Departments in Washington, DC.
    Kulie P; Castel AD; Zheng Z; Powell NN; Srivastava A; Chandar S; McCarthy ML
    AIDS Patient Care STDS; 2020 Dec; 34(12):516-522. PubMed ID: 33296271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptance of HIV pre-exposure prophylaxis (PrEP) referral among a sample of PrEP-eligible emergency department patients.
    Faryar KA; Braun R; Ancona RM; Freiermuth C; Lyons MS
    Am J Emerg Med; 2022 Oct; 60():152-155. PubMed ID: 35973343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated proportion of an urban academic emergency department patient population eligible for HIV preexposure prophylaxis.
    Faryar KA; Ancona RM; Braun RS; Brown JL; Sickles RK; Lyons MS
    Am J Emerg Med; 2021 Oct; 48():198-202. PubMed ID: 33975131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Risk and Pre-Exposure Prophylaxis Eligibility Among Emergency Department Patients.
    Haukoos JS; White DAE; Rowan SE; Lyle C; Gravitz S; Basham K; Godoy A; Kamis K; Hopkins E; Anderson E
    AIDS Patient Care STDS; 2021 Jun; 35(6):211-219. PubMed ID: 34097464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking emergency department patients at risk for human immunodeficiency virus to pre-exposure prophylaxis.
    Mahal J; Deccy S; Seu R
    Am J Emerg Med; 2022 Apr; 54():87-90. PubMed ID: 35151016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP.
    Calabrese SK; Willie TC; Galvao RW; Tekeste M; Dovidio JF; Safon CB; Blackstock O; Taggart T; Kaplan C; Caldwell A; Kershaw TS
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):395-405. PubMed ID: 30973543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review of HIV Pre-exposure Prophylaxis (PrEP) Implementation in U.S. Emergency Departments: Patient Screening, Prescribing, and Linkage to Care.
    Jackson KJ; Chitle P; McCoy SI; White DAE
    J Community Health; 2024 Jun; 49(3):499-513. PubMed ID: 38127296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a 2-step algorithm to identify emergency department patients for HIV pre-exposure prophylaxis.
    Haukoos JS; White DAE; Rowan SE; Lyle C; Gravitz S; Basham K; Godoy A; Kamis K; Hopkins E; Anderson E;
    Am J Emerg Med; 2022 Jan; 51():6-12. PubMed ID: 34649008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving awareness and uptake of pre-exposure HIV prophylaxis amongst service users accessing Sexual Health London, a regional online postal sexually transmitted infection testing health service.
    Caoimhe C; Spate J; Day S
    Int J STD AIDS; 2024 May; 35(6):471-476. PubMed ID: 38300848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT'AIDS cohort.
    Lions C; Cabras O; Cotte L; Huleux T; Gagneux-Brugnon A; Makinson A; Cabié A; Bonnet B; Duvivier C; Hocqueloux L; Cua E; Cheret A; Hustache-Mathieu L; Obry-Roguet V; Jacomet C; Poizot-Martin I;
    BMC Infect Dis; 2019 Mar; 19(1):278. PubMed ID: 30909885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness, Willingness, and Use of Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Washington, DC and Miami-Dade County, FL: National HIV Behavioral Surveillance, 2011 and 2014.
    Patrick R; Forrest D; Cardenas G; Opoku J; Magnus M; Phillips G; Greenberg A; Metsch L; Kharfen M; LaLota M; Kuo I
    J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3(Suppl 3):S375-S382. PubMed ID: 28604442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an Electronic Algorithm for Identifying Cisgender Female Pre-Exposure Prophylaxis Candidates.
    Ridgway JP; Friedman EE; Bender A; Schmitt J; Cronin M; Brown RN; Johnson AK; Hirschhorn LR
    AIDS Patient Care STDS; 2021 Jan; 35(1):5-8. PubMed ID: 33400588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of HIV pre-exposure prophylaxis counselling among non-Hispanic Black youth diagnosed with bacterial sexually transmitted infections in the United States, 2014-2019.
    Watson DL; Shaw PA; Petsis DT; Pickel J; Bauermeister JA; Frank I; Wood SM; Gross R
    J Int AIDS Soc; 2022 Feb; 25(2):e25867. PubMed ID: 35192740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Malaysia: Findings from an online survey.
    Lim SH; Mburu G; Bourne A; Pang J; Wickersham JA; Wei CKT; Yee IA; Wang B; Cassolato M; Azwa I
    PLoS One; 2017; 12(9):e0182838. PubMed ID: 28902857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis.
    Dolling DI; Desai M; McOwan A; Gilson R; Clarke A; Fisher M; Schembri G; Sullivan AK; Mackie N; Reeves I; Portman M; Saunders J; Fox J; Bayley J; Brady M; Bowman C; Lacey CJ; Taylor S; White D; Antonucci S; Gafos M; McCormack S; Gill ON; Dunn DT; Nardone A;
    Trials; 2016 Mar; 17():163. PubMed ID: 27013513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study.
    Hanum N; Cambiano V; Sewell J; Phillips AN; Rodger AJ; Speakman A; Nwokolo N; Asboe D; Gilson R; Clarke A; Miltz AR; Collins S; Lampe FC;
    Lancet Public Health; 2020 Sep; 5(9):e501-e511. PubMed ID: 32888443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does HIV Pre-Exposure Prophylaxis Modify the Effect of Partnership Characteristics on Condom Use? A Cross-Sectional Study of Sexual Partnerships Among Men Who Have Sex with Men in San Francisco, California.
    Prescott MR; Hern J; Petersen M; Santos GM
    AIDS Patient Care STDS; 2019 Apr; 33(4):167-174. PubMed ID: 30932698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing Laboratory Results to Identify Emergency Department Patients with Indications for HIV Pre-Exposure Prophylaxis.
    Carlisle NA; Booth JS; Rodgers JB; Heath SL; Walter LA
    AIDS Patient Care STDS; 2022 Aug; 36(8):285-290. PubMed ID: 35951447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis.
    Levy ME; Patrick R; Gamble J; Rawls A; Opoku J; Magnus M; Kharfen M; Greenberg AE; Kuo I
    PLoS One; 2017; 12(8):e0183521. PubMed ID: 28827821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.